Latest European Society of Cardiology Stories
Large proportions of European coronary patients are not benefiting from cardiac rehabilitation services.
The factors predicting the eventual impact of scientific research (i.e. high citation rates) were successfully identified in abstracts selected for presentation at the annual ESC Congress. Interestingly, predictors of publication in peer reviewed scientific journals differed markedly from those predicting later scientific impact.
Obese adolescents with no symptoms of heart disease already have heart damage.
Nordic walking enables heart failure patients to exercise more intensely than walking without poles.
Statins prevent cancer and reduce death from all causes in heart transplant recipients.
New recommendations on devices, drugs and diagnosis in heart failure were launched at the Heart Failure Congress 2012, 19-22 May, in Belgrade, Serbia, and published in the European Heart Journal.
The latest cardiovascular disease (CVD) prevention guidelines have been overhauled to produce a user friendly document with concise messages that awards greater weight than ever before to evidence from clinical trials and observational population studies.
Undertaking regular jogging increases the life expectancy of men by 6.2 years and women by 5.6 years, reveals the latest data from the Copenhagen City Heart study presented at the EuroPRevent2012 meeting.
The latest research developments to reprogram scar tissue resulting from myocardial infarction (MI) into viable heart muscle cells, were presented at the Frontiers in CardioVascular Biology (FCVB) 2012 meeting, held 30 March to 1 April at the South Kensington Campus of Imperial College in London.
New strategies injecting cardiovascular disease (CVD) patients with vaccines and monoclonal antibodies to combat atherosclerosis could soon change the treatment landscape of heart disease.